Assessing eosinophil count as a marker of immune activation among human immunodeficiency virus-infected persons in sub-Saharan Africa
Chorba, T.L.; Nkengasong, J.; Roels, T.H.; Monga, B.; Maurice, C.; Maran, M.; Djomand, G.
Clinical Infectious Diseases An Official Publication of the Infectious Diseases Society of America 34(9): 1264-1266
2002
ISSN/ISBN: 1537-6591 PMID: 11941554 DOI: 10.1086/339940Document Number: 260562
In 611 human immunodeficiency virus-infected persons who had not yet begun to receive antiretroviral therapy, we evaluated the linear association between absolute eosinophil count (as a surrogate for immune response to helminthic infection) and CD4+ T cell count, and between absolute eosinophil count and log virus load. Overall, no significant correlations were observed between eosinophil count and CD4+ T cell count, or between eosinophil count and log virus load.
Document emailed within 0-6 h
Related Documents
Koyanagi, A.; Humphrey, J.H.; Ntozini, R.; Nathoo, K.; Moulton, L.H.; Iliff, P.; Mutasa, K.; Ruff, A.; Ward, B.; Chidawanyika, H.; Hargrove, J.; Mahomva, A.I.; Majo, F.; Malaba, L.C.; Mbizvo, M.T.; Mzengeza, F.; Ndhlovu, M.; Piwoz, E.; Propper, L.; Rambanepasi, P.; Ruff, A.J.; Tavengwa, N.; Zijenah, L.S.; Zunguza, C.D.; Zvandasara, P. 2011: Morbidity among human immunodeficiency virus-exposed but uninfected, human immunodeficiency virus-infected, and human immunodeficiency virus-unexposed infants in Zimbabwe before availability of highly active antiretroviral therapy Pediatric Infectious Disease Journal 30(1): 45-51Adler, D.; de Bruyn, G.; Laher, F.; Gray, G.; Allan, B.R.; Williamson, A.-L. 2008: Human papillomavirus genotype distribution among human immunodeficiency virus (HIV)-infected and non-HIV-infected women in Soweto, South Africa Journal of Clinical Microbiology 46(12): 4109-4110
Donovan, R.M.; Bush, C.E.; Markowitz, N.P.; Baxa, D.M.; Saravolatz, L.D. 1996: Changes in virus load markers during AIDS-associated opportunistic diseases in human immunodeficiency virus-infected persons Journal of Infectious Diseases 174(2): 401-403
Land, A.M.; Ball, T.Blake.; Luo, M.; Pilon, R.; Sandstrom, P.; Embree, J.E.; Wachihi, C.; Kimani, J.; Plummer, F.A. 2008: Human immunodeficiency virus (HIV) type 1 proviral hypermutation correlates with CD4 count in HIV-infected women from Kenya Journal of Virology 82(16): 8172-8182
Wongsawat, J.; Puthanakit, T.; Kanjanavanit, S.; Hansudewechakul, R.; Ngampiyaskul, C.; Kerr, S.J.; Ubolyam, S.; Suwanlerk, T.; Kosalaraksa, P.; Luesomboon, W.; Ngo-Giang-Huong, N.; Chandara, M.; Saphonn, V.; Ruxrungtham, K.; Ananworanich, J. 2010: CD4 cell count criteria to determine when to initiate antiretroviral therapy in human immunodeficiency virus-infected children Pediatric Infectious Disease Journal 29(10): 966-968
Rockstroh, J.K.; Woitas, R.P.; Brackmann, H.H.; Kupfer, B.; Kaiser, R.; Schneweis, K.E.; Sudhop, T.; Spengler, U. 1998: In vitro cytopathogenicity of the human immunodeficiency virus (HIV)-1 predicts survival in HIV-infected hemophiliacs independent from CD4 cell count European Journal of Medical Research 3(5): 223-230
Puthucheary, S.D.; Ng, K.P.; Hafeez, A.; Raja, N.S.; Hassan, H.H. 2004: Salmonellosis in persons infected with human immunodeficiency virus: a report of seven cases from Malaysia Southeast Asian Journal of Tropical Medicine and Public Health 35(2): 361-365
Spear, G.T.; Landay, A.L.; Sullivan, B.L.; Dittel, B.; Lint, T.F. 1990: Activation of complement on the surface of cells infected by human immunodeficiency virus Journal of Immunology 144(4): 1490-1496
Kania, D.; Sangaré, L.; Sakandé, J.; Koanda, A.; Nébié, Y.K.; Zerbo, O.; Combasséré, A.W.; Guissou, I.P.; Rouet, F.ço. 2009: A new strategy to improve the cost-effectiveness of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and syphilis testing of blood donations in sub-Saharan Africa: a pilot study in Burkina Faso Transfusion 49(10): 2237-2240
Gabrilovich, D.I.; Vasilev, V.B.; Nosikov, V.V.; Serebrovskaia, L.V.; Shepeleva, G.K.; Ivanova, L.A.; Pokrovskiĭ, V.V. 1995: The presence of HIV DNA in the neutrophils of persons infected with the human immunodeficiency virus and the clinical parallels of this phenomenon Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 5: 52-55
Draughon, J.E.; Sheridan, D.J. 2011: Nonoccupational postexposure prophylaxis for human immunodeficiency virus in Sub-Saharan Africa: a systematic review Journal of Forensic Nursing 7(2): 89-96
Kaplan, J.E.; Hu, D.J.; Holmes, K.K.; Jaffe, H.W.; Masur, H.; De Cock, K.M. 1996: Preventing opportunistic infections in human immunodeficiency virus-infected persons: implications for the developing world American Journal of Tropical Medicine and Hygiene 55(1): 1-11
Dyer, J.R.; Kazembe, P.; Vernazza, P.L.; Gilliam, B.L.; Maida, M.; Zimba, D.; Hoffman, I.F.; Royce, R.A.; Schock, J.L.; Fiscus, S.A.; Cohen, M.S.; Eron, J.J. 1998: High levels of human immunodeficiency virus type 1 in blood and semen of seropositive men in sub-Saharan Africa Journal of Infectious Diseases 177(6): 1742-1746
Shakoor, Z. 2003: Serial evaluation of percentage of activated T-lymphocytes in peripheral blood of human immunodeficiency virus infected individuals as a prognostic marker Saudi Medical Journal 24(6): 632-636
Chitra, P.; Bakthavatsalam, B.; Palvannan, T. 2011: Beta-2 microglobulin as an immunological marker to assess the progression of human immunodeficiency virus infected patients on highly active antiretroviral therapy Clinica Chimica Acta; International Journal of Clinical Chemistry 412(11-12): 1151-1154
Koblavi-Dème, Séphania.; Kestens, L.; Hanson, D.; Otten, R.A.; Borget, M-Yolande.; Bilé, Célestin.; Wiktor, S.Z.; Roels, T.H.; Chorba, T.; Nkengasong, J.N. 2004: Differences in HIV-2 plasma viral load and immune activation in HIV-1 and HIV-2 dually infected persons and those infected with HIV-2 only in Abidjan, Côte D'Ivoire AIDS 18(3): 413-419
Lefrère, J-Jacques.; Dahourouh, H.; Dokekias, A.E.; Kouao, M.D.; Diarra, A.; Diop, S.; Tapko, J-Baptiste.; Murphy, E.L.; Laperche, S.; Pillonel, J. 2011: Estimate of the residual risk of transfusion-transmitted human immunodeficiency virus infection in sub-Saharan Africa: a multinational collaborative study Transfusion 51(3): 486-492
Yusim, K.; Peeters, M.; Pybus, O.G.; Bhattacharya, T.; Delaporte, E.; Mulanga, C.; Muldoon, M.; Theiler, J.; Korber, B. 2001: Using human immunodeficiency virus type 1 sequences to infer historical features of the acquired immune deficiency syndrome epidemic and human immunodeficiency virus evolution Philosophical Transactions of the Royal Society of London. Series B Biological Sciences 356(1410): 855-866
Rasheed, S.; Li, Z.; Xu, D.; Kovacs, A. 1996: Presence of cell-free human immunodeficiency virus in cervicovaginal secretions is independent of viral load in the blood of human immunodeficiency virus-infected women American Journal of Obstetrics and Gynecology 175(1): 122-129
Monteiro, J.P.; Freimanis-Hance, L.; Faria, L.B.; Mussi-Pinhata, M.M.; Korelitz, J.; Vannucchi, H.él.; Queiroz, W.; Succi, R.C.M.; Hazra, R. 2009: Both human immunodeficiency virus-infected and human immunodeficiency virus-exposed, uninfected children living in Brazil, Argentina, and Mexico have similar rates of low concentrations of retinol, beta-carotene, and vitamin e Nutrition Research 29(10): 716-722